Diagnostic Modalities in Detecting Cardiovascular Complications of Thalassemia

dc.contributor.authorFianza P.I.
dc.contributor.authorPramono A.A.
dc.contributor.authorGhozali M.
dc.contributor.authorSihite T.A.
dc.contributor.authorSetiabudi D.
dc.contributor.authorSyamsunarno M.R.A.A.
dc.contributor.authorFucharoen S.
dc.contributor.authorPanigoro R.
dc.contributor.otherMahidol University
dc.date.accessioned2023-06-18T17:46:23Z
dc.date.available2023-06-18T17:46:23Z
dc.date.issued2022-08-01
dc.description.abstractThalassemia major is the most common monogenetic disorder worldwide, manifested as chronic hemolytic anemia. This condition leads to the need for chronic blood transfusion to be monitored for an iron overload that may be stored in several tissues and organs, including cardiomyocytes, that might cause a broad spectrum of cardiac iron toxicities such as heart failure conduction delays, myocarditis, and arrhythmias. Non-invasive imaging modalities have their benefits and limitations. Each modality complements and generates a comprehensive diagnostic and monitoring of cardiac siderosis in thalassemia major patients.
dc.identifier.citationReviews in Cardiovascular Medicine Vol.23 No.8 (2022)
dc.identifier.doi10.31083/j.rcm2308267
dc.identifier.eissn21538174
dc.identifier.issn15306550
dc.identifier.scopus2-s2.0-85135935363
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/85659
dc.rights.holderSCOPUS
dc.subjectMedicine
dc.titleDiagnostic Modalities in Detecting Cardiovascular Complications of Thalassemia
dc.typeReview
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85135935363&origin=inward
oaire.citation.issue8
oaire.citation.titleReviews in Cardiovascular Medicine
oaire.citation.volume23
oairecerif.author.affiliationUniversitas Padjadjaran
oairecerif.author.affiliationInstitute of Molecular Biosciences, Mahidol University

Files

Collections